Ignite Creation Date:
2024-05-06 @ 8:19 PM
Last Modification Date:
2024-10-26 @ 3:25 PM
Study NCT ID:
NCT06334757
Status:
RECRUITING
Last Update Posted:
2024-03-28
First Post:
2024-03-21
Brief Title:
Serplulimab Plus Bevacizumab and Chemotherapy for EGFR-mutant Metastatic NSCLC Patients After EGFR-TKI Treatment Failure
Sponsor:
Henan Cancer Hospital
Organization:
Henan Cancer Hospital
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Non-Squamous Non-Small Cell Lung Cancer |
Keywords: